Randomized feasibility trial to improve hydroxyurea adherence in youth ages 10–18 years through community health workers: The HABIT study

INTRODUCTION: The main therapeutic intervention for sickle cell disease (SCD) is hydroxyurea (HU). The effect of HU is largely through dose-dependent induction of fetal hemoglobin (HbF). Poor HU adherence is common among adolescents. METHODS: Our 6-month, two-site pilot intervention trial, “HABIT,”...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pediatr Blood Cancer
Main Authors: Green, Nancy S., Manwani, Deepa, Matos, Sergio, Hicks, April, Soto, Luisa, Castillo, Yina, Ireland, Karen, Stennett, Yvonne, Findley, Sally, Jia, Haomiao, Smaldone, Arlene
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6538388/
https://ncbi.nlm.nih.gov/pubmed/28643377
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.26689
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados